3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Stomach Neoplasms
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Rectal Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Metastatic Gastroesophageal Junction Adenocarcinoma
1
Metastatic Colorectal Adenocarcinoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Hodgkin Disease
1
HER2-positive Colorectal Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastric Cancer Adenocarcinoma Metastatic
1
Esophageal Neoplasms
1
Colorectal Cancer Metastatic
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Advanced/Metastatic Solid Tumors
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Advanced Colorectal Cancer
1
Interventions
Bevacizumab
69
atezolizumab
54
lenvatinib
42
durvalumab
42
Nivolumab
38
pembrolizumab
35
tremelimumab
28
Magnetic Resonance Spectroscopy
21
Specimen Handling
19
tislelizumab
18
sintilimab
17
Ipilimumab
15
Sorafenib
14
regorafenib
13
cabozantinib
13
Radiosurgery
13
Radiotherapy
12
apatinib
11
Blood Specimen Collection
11
Immunoglobulin G
10
camrelizumab
9
Immune Checkpoint Inhibitors
9
Disulfides
9
X-Rays
8
Cyclophosphamide
8
donafenib
7
Oxaliplatin
7
Immunotherapy
7
Folfox protocol
7
Fluorouracil
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
HMPL-013
×
1 year
×
Clear all
No trials found.